CALR and esophageal squamous cell carcinoma: In 2012, Suzuki et al. analyzed the chemoradiotherapy (CRT)-induced expression of calreticulin in resected tumor samples from patients with esophageal squamous cell carcinoma (ESCC, N = 45) [37].